AKKARAJU SRINIVAS

Average Profitability
15.7%
Insider Buys Quantity
7
Insider Buys Sum
$25.99M
Insider Sells Quantity
7
Insider Sells Sum
$42.1M

Insider Activity of AKKARAJU SRINIVAS

According to the SEC Form 4 filings, AKKARAJU SRINIVAS, being in a position of

  1. director at Scholar Rock Holding Corporation,
    оver the last 12 months, has bought 0 shares, and sold 1175713 shares for $34.39M,
    over all time since 2023-10-16, has bought 2189781 share for $15M, and sold 1175713 shares for $34.39M.

The largest purchase of all time was on 2023-10-16 and amounted to 2189781 share of Scholar Rock Holding Corporation for $15M.

The largest sale of all time was on 2024-10-07 and amounted to 1175713 shares of Scholar Rock Holding Corporation for $34.39M.

Biography of AKKARAJU SRINIVAS

No biography is available at this moment.

2024-10-07SaleScholar Rock Holding Corporation
SRRK
director
1.18M
4.967%
$29.25$34.39M-16.8%
2023-12-21PurchaseSyros Pharmaceuticals, Inc.
SYRS
director
904,977
3.271%
$4.42$4M-8%
2023-10-16PurchaseScholar Rock Holding Corporation
SRRK
2.19M
3.2353%
$6.85$15M+68.95%
2020-08-18SaleSyros Pharmaceuticals, Inc.
SYRS
director
317,166
0.6574%
$13.10$4.15M-41.09%
2020-08-17SaleSyros Pharmaceuticals, Inc.
SYRS
director
1,488
0.0033%
$13.00$19,344-36.25%
2020-07-01SaleSyros Pharmaceuticals, Inc.
SYRS
director
9,254
0.0195%
$11.01$101,932-21.41%
2020-06-25SaleSyros Pharmaceuticals, Inc.
SYRS
director
109,944
0.2432%
$11.15$1.23M-16.91%
2020-06-24SaleSyros Pharmaceuticals, Inc.
SYRS
director
97,550
0.2144%
$11.07$1.08M-16.79%
2020-06-23SaleSyros Pharmaceuticals, Inc.
SYRS
director
101,906
0.2283%
$11.11$1.13M-15.44%
2019-04-09PurchaseSyros Pharmaceuticals, Inc.
SYRS
director
533,332
1.4074%
$7.50$4M+3.52%
2018-01-31PurchaseSyros Pharmaceuticals, Inc.
SYRS
director
209,424
0.6882%
$9.55$2M+14.51%
2017-12-14PurchaseSyros Pharmaceuticals, Inc.
SYRS
director
26,600
0.1012%
$8.99$239,134+22.94%
2017-12-13PurchaseSyros Pharmaceuticals, Inc.
SYRS
director
68,400
0.2568%
$8.97$613,548+21.59%
2017-12-12PurchaseSyros Pharmaceuticals, Inc.
SYRS
director
14,774
0.0554%
$9.40$138,876+15.97%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.